DIGITAL EDITION

ARCHIVES

CURRENT ISSUE

Letter to the Editor: Discussing ANT1 role in Amyotrophic Lateral Sclerosis pathogenesis

Innov Clin Neurosci. 2018;15(3–4):11–14 Dear Editor: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with a rapid progression, affecting motor neurons in the brain and spinal cord, ultimately leading to

Letter to the Editor: Olanzapine and Diabetic Ketoacidosis: What is the Underlying Mechanism?

Innov Clin Neurosci. 2018;15(3–4):11–14 Dear Editor: Recently, Iwaku et al1 reported a detailed case of olanzapine-related acute-onset Type 1 diabetes with ketoacidosis.1 They concluded that olanzapine sometimes can cause sudden

Letter to the Editor: Prolactin levels in Patients with Schizophrenia who were switched from daily to once-monthly Aripiprazole treatment

Innov Clin Neurosci. 2018;15(3–4):11–14 Dear Editor: Schizophrenia is a chronic and progressive psychiatric disorder requiring long-term treatment with antipsychotics. The use of long-acting injectable antipsychotics (LAI) has been shown to

Editorial Message and Issue Highlights–Vol. 15, No. 1–2, January-February 2018

Dear Colleagues: Welcome to the January-February 2018 issue of Innovations in Clinical Neuroscience (ICNS). This is a milestone year for us as it marks the beginning of our 15th year